A multicenter clinical study on transanal endoscopic sphincter-preserving resection of low rectal tumors - Takeaways - MDSpire

A multicenter clinical study on transanal endoscopic sphincter-preserving resection of low rectal tumors

  • By

  • Xiaoke Hu

  • Shuaishuai Fan

  • Jia Xue

  • Hongrui Li

  • Guangya Sun

  • Zeyu Cai

  • Wang Le

  • Ruixue Wang

  • Haiqing Hu

  • June 12, 2026

  • 0 min

Share

  • 1

    Transanal Endoscopic Sphincter-Preserving Resection (TA-ESPR) is a minimally invasive technique for treating low rectal tumors.

  • 2

    A study of 37 patients showed a 100% en bloc and complete resection rate with no severe adverse events.

  • 3

    The mean follow-up duration was 36.86 months, with a recurrence rate of 2.7% among patients treated with TA-ESPR.

  • 4

    TA-ESPR effectively preserves anal function and improves postoperative quality of life for patients with low rectal tumors.

  • 5

    The study highlights TA-ESPR as a viable option for patients refusing radical surgery due to various clinical dilemmas.

Original Source(s)

A multicenter clinical study on transanal endoscopic sphincter-preserving resection of low rectal tumors

  • by Xiaoke Hu, Shuaishuai Fan, Jia Xue, Hongrui Li, Guangya Sun, Zeyu Cai, Wang Le, Ruixue Wang, Haiqing Hu

  • June 12, 2026

Related Content

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib

Case Report: Granular cell tumor of the axillary tail mimicking node-positive breast carcinoma — two cases with imaging–pathology correlation

Research progress on the etiology and pathogenesis of pancreatic cancer: a narrative review